7,629.58

+49.51

+0.65%

52,280.00

+509.69

+0.98%

25,644.85

+207.85

+0.82%

2,840.95

+29.11

+1.04%

4.9080

-0.0210

-0.43%

18.62

-0.80

-4.12%

3,970.00

+71.10

+1.82%

77,313.15

-706.85

-0.91%

Crude Oil Dec 26

97.13

-6.99

-6.71%

US Private Equity

10,850.63

-82.20

-0.75%

Toronto - Free Realtime Quote CAD

Aurora Cannabis Inc. (ACB.TO)

5.98 +0.32 (+5.65%)

As of 11:17:58 AM EST. Market Open.

Loading Chart for ACB.TO

Chart Range Bar

Interval:

In partnership with ChartIQ

Top 3 Canadian Healthcare Stocks To Watch In October 2026

Top 3 Canadian Healthcare Stocks To Watch In October 2026

Aurora Named to TIME Canada's Best Companies 2026 List

Aurora Named to TIME Canada's Best Companies 2026 List

Aurora Named to TIME Canada's Best Companies 2026 List

Aurora Named to TIME Canada's Best Companies 2026 List

Aurora Cannabis Inc. Announces Filing and Mailing of the Management Information Circular in Connection with the Annual General Meeting of Shareholders

Aurora Cannabis Inc. Announces Filing and Mailing of the Management Information Circular in Connection with the Annual General Meeting of Shareholders

Aurora Cannabis Inc. Announces Filing and Mailing of the Management Information Circular in Connection with the Annual General Meeting of Shareholders

Aurora Cannabis Inc. Announces Filing and Mailing of the Management Information Circular in Connection with the Annual General Meeting of Shareholders

Aurora Cannabis Generates 55% Revenue Outside Canada as Medical Sales Surge – Quarterly Update Report

Aurora Cannabis Generates 55% Revenue Outside Canada as Medical Sales Surge – Quarterly Update Report

Aurora Cannabis Generates 55% Revenue Outside Canada as Medical Sales Surge – Downloadable Quarterly Update Report

Aurora Q4 Earnings Call Flags Reset Year as Canada Pressure Weighs

Aurora Q4 Earnings Call Flags Reset Year as Canada Pressure Weighs

Aurora (ACB) Q4 2026 Earnings Transcript

Aurora (ACB) Q4 2026 Earnings Transcript

Aurora Cannabis Q4 Earnings Call Highlights

Aurora Cannabis Q4 Earnings Call Highlights

Aurora Cannabis Down 4% in U.S. Pre-Market After It Forecast a Decline in Fiscal Year 2027 Total Net Revenue

Aurora Cannabis Down 4% in U.S. Pre-Market After It Forecast a Decline in Fiscal Year 2027 Total Net Revenue

Mobilize your Website

View Site in Mobile | Classic

Share by: